Search research articles
Contact Us
Filters
Showing results (51-60 of 139) with videos related to
Page
of 14
Sort By:
Journal of the Endocrine Society
|
October 17, 2022
The Use of Ceramides to Predict Metabolic Response to Metformin in Women With PCOS
Anu Sharma, Benjamin Krick, Ying Li, et al.
Nature Reviews. Cardiology
|
March 27, 2021
Ceramides and other sphingolipids as drivers of cardiovascular disease
Ran Hee Choi, Sean M Tatum, J David Symons, et al.
Annual Review of Nutrition
|
May 18, 2022
The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease
Rebekah J Nicholson, Marie K Norris, Annelise M Poss, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 10, 2002
Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans
Richard C Ho, Kevin P Davy, Matthew S Hickey, et al.
European Heart Journal Open
|
May 5, 2025
The role of sphingolipids in heart failure
Rana Hamouche, Scott A Summers, William L Holland, et al.
Biochemical Society Transactions
|
July 31, 2024
Ceramide microdomains: the major influencers of the sphingolipid media platform
Mariah Weber-Stout, Rebekah J Nicholson, Carlos Dave C Dumaguit, et al.
Global Qualitative Nursing Research
|
May 20, 2020
An Interpretive Description of Women's Experience in Coordinated, Multidisciplinary Treatment for an Eating Disorder
Kary Woodruff, Lauren Clark, Elizabeth Joy, et al.
Journal of Multidisciplinary Healthcare
|
January 29, 2024
A Retrospective Chart Review Suggests That Coordinated, Multidisciplinary Treatment for Patients with Anorexia Nervosa Improves Odds of Weight Restoration
Kary Woodruff, Elizabeth A Joy, Ryan D Burns, et al.
The Journal of Biological Chemistry
|
November 12, 2013
Ceramides and glucosylceramides are independent antagonists of insulin signaling
Jose A Chavez, M Mobin Siddique, Siew Tein Wang, et al.
The Journal of Biological Chemistry
|
October 6, 2016
A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes
Min Park, Vincent Kaddai, Jianhong Ching, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 139) with videos related to
Sort By:
Page
of 14
Journal of the Endocrine Society
|
October 17, 2022
The Use of Ceramides to Predict Metabolic Response to Metformin in Women With PCOS
Anu Sharma, Benjamin Krick, Ying Li, et al.
Nature Reviews. Cardiology
|
March 27, 2021
Ceramides and other sphingolipids as drivers of cardiovascular disease
Ran Hee Choi, Sean M Tatum, J David Symons, et al.
Annual Review of Nutrition
|
May 18, 2022
The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease
Rebekah J Nicholson, Marie K Norris, Annelise M Poss, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 10, 2002
Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans
Richard C Ho, Kevin P Davy, Matthew S Hickey, et al.
European Heart Journal Open
|
May 5, 2025
The role of sphingolipids in heart failure
Rana Hamouche, Scott A Summers, William L Holland, et al.
Biochemical Society Transactions
|
July 31, 2024
Ceramide microdomains: the major influencers of the sphingolipid media platform
Mariah Weber-Stout, Rebekah J Nicholson, Carlos Dave C Dumaguit, et al.
Global Qualitative Nursing Research
|
May 20, 2020
An Interpretive Description of Women's Experience in Coordinated, Multidisciplinary Treatment for an Eating Disorder
Kary Woodruff, Lauren Clark, Elizabeth Joy, et al.
Journal of Multidisciplinary Healthcare
|
January 29, 2024
A Retrospective Chart Review Suggests That Coordinated, Multidisciplinary Treatment for Patients with Anorexia Nervosa Improves Odds of Weight Restoration
Kary Woodruff, Elizabeth A Joy, Ryan D Burns, et al.
The Journal of Biological Chemistry
|
November 12, 2013
Ceramides and glucosylceramides are independent antagonists of insulin signaling
Jose A Chavez, M Mobin Siddique, Siew Tein Wang, et al.
The Journal of Biological Chemistry
|
October 6, 2016
A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes
Min Park, Vincent Kaddai, Jianhong Ching, et al.
Page
of 14